{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:04:18Z","timestamp":1790417058821,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["75-15-2020-913"],"award-info":[{"award-number":["75-15-2020-913"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biopha.2021.111900","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T13:27:16Z","timestamp":1626182836000},"page":"111900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis"],"prefix":"10.1016","volume":"141","author":[{"given":"Vasily A.","family":"Kudinov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana I.","family":"Torkhovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara S.","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina E.","family":"Morozevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael I.","family":"Artyushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Yu.","family":"Zubareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey S.","family":"Markin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111900_bib1","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111900_bib2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2021.111900_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.numecd.2019.07.022","article-title":"Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous origin","volume":"30","author":"Bonnefont-Rousselot","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2021.111900_bib4","first-page":"325","article-title":"High-density lipoproteins: biology, epidemiology, and clinical management","volume":"33","author":"Choi","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111900_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2019.01.001","article-title":"HDL cholesterol and ASCVD risk stratification: a debate","volume":"283","author":"Barter","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111900_bib6","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.2174\/0929867323666160809093009","article-title":"Cholesterol efflux and reverse cholesterol transport: experimental approaches","volume":"23","author":"Litvinov","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111900_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trsl.2016.02.008","article-title":"Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy","volume":"173","author":"Annema","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2021.111900_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.plipres.2017.12.001","article-title":"Determinants of cholesterol efflux capacity in humans","volume":"69","author":"Talbot","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.111900_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1194\/jlr.P093823","article-title":"Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men","volume":"60","author":"Cahill","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib11","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.2174\/0929867326666190201142321","article-title":"Cardioprotective properties of HDL: structural and functional considerations","volume":"27","author":"Pappa","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111900_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228737","article-title":"High-density lipoproteins as homeostatic nanoparticles of blood plasma","volume":"21","author":"Kudinov","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111900_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18087\/cardio.2018.3.10101","article-title":"Dysfunctional high-density lipoproteins: role in atherogenesis and potential targets for phospholipid therapy","author":"Torchovskaya","year":"2018","journal-title":"Kardiologiia"},{"key":"10.1016\/j.biopha.2021.111900_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ebiom.2019.04.012","article-title":"APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm","volume":"43","author":"Mart\u00ednez-L\u00f3pez","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2021.111900_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2016.04.012","article-title":"The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis","volume":"457","author":"Yamamoto","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2021.111900_bib16","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/ATVBAHA.117.309201","article-title":"Large-scale analysis of determinants, stability, and heritability of high-density lipoprotein cholesterol efflux capacity","volume":"37","author":"Koekemoer","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2021.111900_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacl.2019.02.004","article-title":"Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency","volume":"13","author":"Zakiev","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.biopha.2021.111900_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1134\/S106816201905011X","article-title":"Human blood plasma lipidome: opportunities and prospects of its analysis in medical chemistry","volume":"45","author":"Torkhovskaya","year":"2019","journal-title":"Russ. J. Bioorganic Chem."},{"key":"10.1016\/j.biopha.2021.111900_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1194\/jlr.M063701","article-title":"Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway","volume":"57","author":"Pamir","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10557-019-06865-1","article-title":"HDL-targeted therapies during myocardial infarction","volume":"33","author":"Sposito","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2021.111900_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2019.08.043","article-title":"Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide","volume":"297","author":"Suematsu","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111900_bib22","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1021\/bi0608717","article-title":"Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterophilicity and cholesterol efflux via SR-BI","volume":"45","author":"Pownall","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2021.111900_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2009.10.002","article-title":"HDL superphospholipidation enhances key steps in reverse cholesterol transport","volume":"209","author":"Tchoua","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.biopha.2021.111900_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1194\/jlr.RA119000258","article-title":"Composition-function analysis of HDL subpopulations: influence of lipid composition on particle functionality","volume":"61","author":"Niisuke","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacl.2010.08.018","article-title":"Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology?","volume":"4","author":"Tardif","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.biopha.2021.111900_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1194\/jlr.M400477-JLR200","article-title":"Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release","volume":"46","author":"Hajj Hassan","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib27","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111900_bib28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1161\/ATVBAHA.115.305504","article-title":"High-density lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease","volume":"35","author":"Agarwala","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2021.111900_bib29","doi-asserted-by":"crossref","first-page":"36596","DOI":"10.1074\/jbc.M006924200","article-title":"High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI","volume":"275","author":"Yancey","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111900_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9150(92)90195-M","article-title":"Essential phospholipids modify immunological functions and reduce experimental atherosclerosis in rabbits","volume":"93","author":"Wojcicki","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111900_bib31","unstructured":"K.-J. Gundermann, The \"essential\" phospholipids as a membrane therapeutic, Polish Section of European Society of Biochemical Pharmacology. Institute of Polish Section of European Society of Biochemical Pharmacology Institute of Pharmacology and Toxicology, Medical Academy, Szczecin, 1993."},{"key":"10.1016\/j.biopha.2021.111900_bib32","unstructured":"S.S. Markin, L.I. Olbinskaya, T.I. Torkhovskaya, Phospholipid therapy of atherosclerosis, Moscow, Belyi Veter, 2016."},{"key":"10.1016\/j.biopha.2021.111900_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mol.0000169345.15450.4b","article-title":"Enhancing reverse cholesterol transport: the case for phosphatidylcholine therapy","volume":"16","author":"Pownall","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.biopha.2021.111900_bib34","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1258\/ebm.2010.009320","article-title":"Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits","volume":"235","author":"Cho","year":"2010","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111900_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011792","article-title":"HDL Phospholipids, but not cholesterol distinguish acute coronary syndrome from stable coronary artery disease","volume":"8","author":"Meikle","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2021.111900_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.atherosclerosis.2007.12.030","article-title":"The effect of large unilamellar vesicles on vascular function in patients with coronary atherosclerosis","volume":"200","author":"Anderson","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111900_bib37","first-page":"1323","article-title":"Apo A-II participates in HDL-liposome interaction by the formation of new pre-\u03b2 mobility particles and the modification of liposomes","volume":"2010","author":"Wr\u00f3blewska","year":"1801","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2021.111900_bib38","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1039\/C6CS00409A","article-title":"Lipid-based nanovesicles for nanomedicine","volume":"45","author":"Grimaldi","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2021.111900_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000112961","article-title":"Nanomedicine: application of nanobiotechnology in medical practice","volume":"17","author":"Jain","year":"2008","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.biopha.2021.111900_bib40","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/IJN.S243223","article-title":"Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2021.111900_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/NSA.S243017","article-title":"Nanoparticle drug delivery systems for \u03b1-mangostin","volume":"13","author":"Wathoni","year":"2020","journal-title":"Nanotechnol. Sci. Appl."},{"key":"10.1016\/j.biopha.2021.111900_bib42","doi-asserted-by":"crossref","first-page":"704","DOI":"10.18097\/PBMC20166206704","article-title":"Investigation of efficacy of phospholipovit for correction of the hepatic encephalopathy","volume":"62","author":"Kudinov","year":"2016","journal-title":"Biomed. Khimiya"},{"key":"10.1016\/j.biopha.2021.111900_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.18097\/PBMC20156101007","article-title":"Mass spectrometry analysis of blood plasma lipidome as method of disease diagnostics, evuation of effectiveness and optimization of drug therapy","volume":"61","author":"Lokhov","year":"2015","journal-title":"Biomed. Khimiya"},{"key":"10.1016\/j.biopha.2021.111900_bib44","first-page":"306","article-title":"Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI","volume":"2008","author":"Lorenzi","year":"1781","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2021.111900_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2019.02.022","article-title":"New findings on the incorporation of essential oil components into liposomes composed of lipoid S100 and cholesterol","volume":"561","author":"Hammoud","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.111900_bib46","series-title":"Anal. Lipids Lipoproteins","first-page":"204","article-title":"Preparative ultracentrifugal laboratory procedures and suggestions for lipoprotein analysis","author":"Lindgren","year":"1975"},{"key":"10.1016\/j.biopha.2021.111900_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1194\/jlr.M600094-JLR200","article-title":"High density lipoprotein subfractions: isolation, composition, and their duplicitous role in oxidation","volume":"48","author":"McPherson","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1194\/jlr.M500466-JLR200","article-title":"Measurement of cholesterol bidirectional flux between cells and lipoproteins","volume":"47","author":"Zimetti","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-2275(20)33373-3","article-title":"Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids\/free cholesterol ratio and of the hdl size distribution","volume":"40","author":"Davit-Spraul","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171993","article-title":"Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level","volume":"12","author":"Paavola","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111900_bib51","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.febslet.2015.02.028","article-title":"Structural stability and functional remodeling of high-density lipoproteins","volume":"589","author":"Gursky","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2021.111900_bib52","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-2275(20)31997-0","article-title":"Influence of phospholipid depletion on the size, structure, and remodeling of reconstituted high-density lipoproteins","volume":"41","author":"Rye","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib53","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1134\/S1068162018060092","article-title":"High density lipoproteins phosphatidylcholine as a regulator of reverse cholesterol transport","volume":"44","author":"Torkhovskaya","year":"2018","journal-title":"Russ. J. Bioorganic Chem."},{"key":"10.1016\/j.biopha.2021.111900_bib54","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2021.111900_bib55","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-2275(20)32113-1","article-title":"Cell cholesterol efflux: integration of old and new observations provides new insights","volume":"40","author":"Rothblat","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib56","doi-asserted-by":"crossref","first-page":"19719","DOI":"10.1073\/pnas.1113021108","article-title":"ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter","volume":"108","author":"Tarling","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2021.111900_bib57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0005-2760(81)90268-X","article-title":"Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins dependence on cholesterol content and phospholipid composition","volume":"665","author":"Damen","year":"1981","journal-title":"Biochim. Biophys. Acta (BBA)-Lipids Lipid Metab."},{"key":"10.1016\/j.biopha.2021.111900_bib58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1432-1327.1998.2530328.x","article-title":"The C\u2010terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high\u2010density lipoproteins","volume":"253","author":"Lambert","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biopha.2021.111900_bib59","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.111900_bib60","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1194\/jlr.M041038","article-title":"Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma","volume":"55","author":"Miyazaki","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib61","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1194\/jlr.M800399-JLR200","article-title":"Phospholipids mediated conversion of HDLs generates specific apoA-II pre-\u03b2 mobility particles","volume":"50","author":"Wr\u00f3blewska","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(98)00132-4","article-title":"Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate","volume":"140","author":"Wilson","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111900_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1194\/jlr.M300231-JLR200","article-title":"In vivo modulation of HDL phospholipid has opposing effects on SR-BI-and ABCA1-mediated cholesterol efflux","volume":"45","author":"Yancey","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","article-title":"Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux","volume":"50","author":"Sankaranarayanan","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2021.111900_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2014.09.009","article-title":"Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine","volume":"146","author":"Fan","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.111900_bib66","first-page":"96","article-title":"Pharmacological targets for correction of dyslipidemias. Opportunities and prospects of therapeutic use","volume":"12","author":"Kudinov","year":"2018","journal-title":"Biochem. Suppl. Ser. B Biomed. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100682X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100682X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:40:24Z","timestamp":1777574424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100682X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":66,"alternative-id":["S075333222100682X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111900","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111900"}}